Living Donor Liver Transplant: Update on Status and Current Outcomes
WEDNESDAY, SEPT. 10, 2014
John R. Lake, MD, University of Minnesota Medical Center, Fairview
The most effective therapy for end-stage liver disease is transplantation. Improved surgical techniques and the introduction of new immunosuppressive agents have enhanced the long-term results of liver transplantation, leading to an increased demand for liver transplantation that exceeds the number of potential donor organs. Liver transplantation from living donors (LDLT) is currently the most effective alternative to overcome the problem of organ shortage for adults. This session will discuss the current role of LDLT, and the surgical techniques and recipient outcomes.
- Examine the current status and outcomes for live donor liver transplantation.
- Compare the use of left lobe versus right lobe for liver transplantation and the considerations for both the recipient and the donor.
- Debate whether a change in allocation guidelines would lead to an increased need for more live donors.
- Discuss the importance of obtaining appropriate informed consent for living donor transplantation.
These materials are intended ONLY for pharmacists and pharmacy technicians that attended "Living Donor Liver Transplant: Update on Status and Current Outcomes" held at 4:15 p.m. Wed., Sept. 10, 2014. This session was part of the "23rd Annual National Conference" held in Chicago, Ill. on Sept. 10-12, 2014.
The prerequisite to this process is completing the 23rd Annual National Conference Post-Assessment and Evaluation. If there is a Prerequisite section above and the Status field is blank, click on '23rd Annual National Conference' to open the Assessment and Evaluation.
- 0.75 ACPE - Pharmacists